Biohaven Pharma (BHVN) Tops Q2 EPS by 31c

Biohaven Pharma (NYSE: BHVN) reported Q2 EPS of ($1.63), $0.31 better than the analyst estimate of ($1.94).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

You May Also Be Interested In

• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• SK Hynix (SKHY) call put ratio 1.2 calls to 1 put as share price up 4.7%
• Micron Technology (MU) call put ratio 1.5 calls to 1 put amid share price up 3.3%